THANK YOU FOR SUBSCRIBING
As the season changes, and Fall is upon us – we continue to remain steadfast focused on our vision of Saving Lives through technology. As we evolve our technology and continue to release new, game-changing functionality to the market – we constantly find additional areas of value that our solutions offer to patients, providers and medical device manufacturers. To continue our mission of raising awareness to our market (in the US and Globally), and researching new innovations – such as TrackMy Meds (which will positively disrupt the patient pharmaceutical recall tracking space with our TrackMy platform) - it is exciting to announce that Paul Edwards has agreed to join our Board of Advisors! Paul is helping strategize additional markets (business growth), and facilitating key introductions to raise awareness of the challenges we solve in the healthcare ecosystem. Welcome to the Team Paul!
Paul joined Infectious Disease Connect (IDC) as the Chief Strategy Officer after its merger with ILUM health solutions (An independent subsidiary of Merck & Co), where he was the CEO. Paul’s current responsibilities include leading all facets of the Public Health Surveillance business as well as developing, communicating, and executing IDC’s core strategy. As part of this role, he is responsible for facilitating and driving key strategic initiatives from inception to execution.
Prior to IDC and ILUM, Paul was with Merck & Co Inc. for 22 years where he held several leadership positions during his tenure, including Global Brand Leader (NJ, USA); Business Operations Director (Moscow, Russia); Franchise Leader (Munich, Germany), European Marketing Director (Munich Germany) and Business Unit Director (Johannesburg, South Africa). In these roles, Paul has gained leadership experience both in the US and abroad and has held both strategic and operational roles. It is from this global perspective that Paul understands the critical importance of always focusing on products and services that strive to improve patient health outcomes.
Paul holds an MBA from Oxford Brookes University in the United Kingdom.